
Pioneering Science for Patient Choice
Our Approach
Harnessing established science to advance oral therapies for bradykinin mediated diseases.
View our Science
Pharvaris aims to deliver oral bradykinin B2 receptor antagonists to help address unmet needs and improve standard of care.
View our PipelineAt Pharvaris, we understand the impact of a rare disease; we aim to address existing unmet needs and provide choices for those living with bradykinin-mediated diseases.
Our Disease Focus
Pharvarians are committed to those whose lives are impacted by bradykinin-mediated diseases, and value our relationships with the organizations that offer support.
HAE CommunityOur legacy, scientific expertise, and values drive our passion as we aspire to provide choice to people living with bradykinin-mediated diseases.
About Us

